Accounts Payable - Corcept Therapeutics Inc (NASDAQ:CORT) - Alpha Spread

Corcept Therapeutics Inc
NASDAQ:CORT

Watchlist Manager
Corcept Therapeutics Inc Logo
Corcept Therapeutics Inc
NASDAQ:CORT
Watchlist
Price: 43.93 USD 1.5% Market Closed
Market Cap: 4.8B USD
Have any thoughts about
Corcept Therapeutics Inc?
Write Note

Corcept Therapeutics Inc
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Corcept Therapeutics Inc
Accounts Payable Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
Corcept Therapeutics Inc
NASDAQ:CORT
Accounts Payable
$19.5m
CAGR 3-Years
28%
CAGR 5-Years
23%
CAGR 10-Years
22%
Johnson & Johnson
NYSE:JNJ
Accounts Payable
$8.8B
CAGR 3-Years
1%
CAGR 5-Years
5%
CAGR 10-Years
4%
Bristol-Myers Squibb Co
NYSE:BMY
Accounts Payable
$3.8B
CAGR 3-Years
1%
CAGR 5-Years
13%
CAGR 10-Years
5%
Pfizer Inc
NYSE:PFE
Accounts Payable
$5.1B
CAGR 3-Years
6%
CAGR 5-Years
5%
CAGR 10-Years
5%
Merck & Co Inc
NYSE:MRK
Accounts Payable
$3.5B
CAGR 3-Years
-3%
CAGR 5-Years
2%
CAGR 10-Years
4%
Eli Lilly and Co
NYSE:LLY
Accounts Payable
$2.9B
CAGR 3-Years
22%
CAGR 5-Years
20%
CAGR 10-Years
10%

See Also

What is Corcept Therapeutics Inc's Accounts Payable?
Accounts Payable
19.5m USD

Based on the financial report for Jun 30, 2024, Corcept Therapeutics Inc's Accounts Payable amounts to 19.5m USD.

What is Corcept Therapeutics Inc's Accounts Payable growth rate?
Accounts Payable CAGR 10Y
22%

Over the last year, the Accounts Payable growth was 144%. The average annual Accounts Payable growth rates for Corcept Therapeutics Inc have been 28% over the past three years , 23% over the past five years , and 22% over the past ten years .

Back to Top